Tag - Janney Montgomery Scott

Janney Montgomery Scott launched coverage of Interpace Biosciences (NASDAQ:IDXG) with a “buy” rating and fair value estimate of $12. The stock closed at $4.81 on April 14. Analyst Paul Knight writes that Interpace has...